Science37: Using Technology To Enable Remote, Clinical Trials, with Belinda Tan
socalTECH
MAY 8, 2017
The company is backed by more than $67M in funding from such investors as Glynn Capital Management, GV (formerly Google Ventures), Amgen Ventures, Lux Capital, Redmile Group, dRx Capital (a Qualcomm and Novartis joint investment company), and Sanofi Ventures. Belinda Tan: Most of our trials are Phase 2 and Phase 3 studies.
Let's personalize your content